Mood disorders

Biotechnology, Featured, Genetics, Mood disorders, Neurocognitive disorders, Neuroscience
CRISPR-Cas9 gene editing shown to change social behaviors in animal models

A Georgia State University research team has used CRISPR gene editing technology to show how the Avpr1a receptor affects social behaviors in hamsters. CRISPR-Cas9 technology was utilized by a team

Diet, Gastroenterology, Med Lifestyle, Medical News, Metabolic syndrome, Mood disorders, Neurocognitive disorders, Neuroscience
Gut metabolite found to affect brain function through reduction of glial cells

A Caltech research team has demonstrated how gut metabolite, 4-ethylphenyl sulfate (4EPS), induces anxiety-like behaviors in mice through the reduction of oligodendrocytes. For the last decade, many papers have been

Biotechnology, COVID-19, Medical News, Mood disorders, Neuroscience, Pharmaceuticals, World health
Antidepressant fluvoxamine shown to significantly reduce hospitalizations due to COVID-19

A new randomized-controlled trial has shown fluvoxamine, an antidepressant, significantly reduces hospitalizations due to COVID-19 (79 [11%] of 741 in the fluvoxamine group .vs. 119 [16%] of 756 in the

Exercise, Medical News, Mood disorders, Neurocognitive disorders, Neuroscience, World health
Physical exercise associated with lower long-term incidence of anxiety

Over the course of a multidecade longitudinal study, the researchers discovered that exercise reduces the risk of incurring future anxiety disorders by 62%. In a recently published study, a Swedish

Exercise, Longevity, Medical News, Metabolic syndrome, Mood disorders
Physical exercise and antidepressants similarly effective in reducing depressive symptoms in the short-term

When compared to the antidepressant treatment group, physical exercise as a therapy alternative was equally beneficial in alleviating depressive symptoms in the short term (1 month). Depression is a common

Medical News, Mood disorders, Neuroscience, Pharmaceuticals
Psychedelics promote growth of neural connections that have been lost due to depression

The researchers observed an increase in the number and size of dendritic spines after 24 hours of psilocybin administration. The alterations were still visible a month later. Furthermore, after being